J.P. Morgan Maintains a Sell Rating on GSK plc (GSK)

GSK plc (NYSE:GSK) is one of the best pharma stocks to invest in. J.P. Morgan analyst Richard Vosser maintained a Sell rating on GSK plc (NYSE:GSK) on December 8, setting a price target of £17.00. Is GSK plc (GSK) the Best Undervalued UK Stock to Buy Right Now? In a separate development, GSK plc (NYSE:GSK) announced on November 20 that its subsidiary, TESARO, Inc., confirmed the initiation of litigation against AnaptysBio, Inc. in the Delaware Chancery Court, contending that the recent conduct by Anaptys ...